BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37973176)

  • 1. Mortality surrogates in combined pulmonary fibrosis and emphysema.
    Zhao A; Gudmundsson E; Mogulkoc N; van Moorsel C; Corte TJ; Vasudev P; Romei C; Chapman R; Wallis TJM; Denneny E; Goos T; Savas R; Ahmed A; Brereton CJ; van Es HW; Jo H; De Liperi A; Duncan M; Pontoppidan K; De Sadeleer LJ; van Beek F; Barnett J; Cross G; Procter A; Veltkamp M; Hopkins P; Moodley Y; Taliani A; Taylor M; Verleden S; Tavanti L; Vermant M; Nair A; Stewart I; Janes SM; Young AL; Barber D; Alexander DC; Porter JC; Wells AU; Jones MG; Wuyts WA; Jacob J
    Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 37973176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.
    Schmidt SL; Nambiar AM; Tayob N; Sundaram B; Han MK; Gross BH; Kazerooni EA; Chughtai AR; Lagstein A; Myers JL; Murray S; Toews GB; Martinez FJ; Flaherty KR
    Eur Respir J; 2011 Jul; 38(1):176-83. PubMed ID: 21148225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
    Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
    Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema.
    Yamamoto Y; Hirata H; Shiroyama T; Kuge T; Matsumoto K; Yoneda M; Yamamoto M; Naito Y; Suga Y; Fukushima K; Miyake K; Koyama S; Iwahori K; Nagatomo I; Takeda Y; Kumanogoh A
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1495-1506. PubMed ID: 35801120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features.
    Inomata M; Ikushima S; Awano N; Kondoh K; Satake K; Masuo M; Kusunoki Y; Moriya A; Kamiya H; Ando T; Yanagawa N; Kumasaka T; Ogura T; Sakai F; Azuma A; Gemma A; Takemura T
    BMC Pulm Med; 2014 Jun; 14():104. PubMed ID: 24972672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.
    Akagi T; Matsumoto T; Harada T; Tanaka M; Kuraki T; Fujita M; Watanabe K
    Respir Med; 2009 Aug; 103(8):1209-15. PubMed ID: 19251407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.
    Ryerson CJ; Hartman T; Elicker BM; Ley B; Lee JS; Abbritti M; Jones KD; King TE; Ryu J; Collard HR
    Chest; 2013 Jul; 144(1):234-240. PubMed ID: 23370641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry.
    Kim HJ; Snyder LD; Neely ML; Hellkamp AS; Hotchkin DL; Morrison LD; Bender S; Leonard TB; Culver DA;
    Lung; 2022 Feb; 200(1):21-29. PubMed ID: 34997268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis.
    Yoon HY; Kim TH; Seo JB; Lee SM; Lim S; Lee HN; Kim N; Han M; Kim DS; Song JW
    Respirology; 2019 Jan; 24(1):55-62. PubMed ID: 30136753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis.
    Zhang L; Zhang C; Dong F; Song Q; Chi F; Liu L; Wang Y; Che C
    BMC Pulm Med; 2016 Nov; 16(1):137. PubMed ID: 27809901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.
    Sangani R; Ghio A; Culp S; Patel Z; Sharma S
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1873-1885. PubMed ID: 34188464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema.
    Jacob J; Bartholmai BJ; Rajagopalan S; Karwoski R; Nair A; Walsh SLF; Barnett J; Cross G; Judge EP; Kokosi M; Renzoni E; Maher TM; Wells AU
    Respirology; 2018 Jun; 23(6):593-599. PubMed ID: 29237236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
    Sato S; Koike T; Hashimoto T; Ishikawa H; Okada A; Watanabe T; Tsuchida M
    Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):216-23. PubMed ID: 27052999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema].
    Ma JW; Li ZH; Xu H; Wang HJ; Kang J; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):173-6. PubMed ID: 23856138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual Change in Pulmonary Function and Clinical Characteristics of Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis: Over a 3-Year Follow-up.
    Kim YJ; Shin SH; Park JW; Kyung SY; Kang SM; Lee SP; Sung YM; Kim YK; Jeong SH
    Tuberc Respir Dis (Seoul); 2014 Jul; 77(1):18-23. PubMed ID: 25114699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone.
    Sugino K; Ishida F; Kikuchi N; Hirota N; Sano G; Sato K; Isobe K; Sakamoto S; Takai Y; Homma S
    Respirology; 2014 Feb; 19(2):239-245. PubMed ID: 25198924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation.
    Takahashi T; Terada Y; Pasque MK; Liu J; Byers DE; Witt CA; Nava RG; Puri V; Kozower BD; Meyers BF; Kreisel D; Patterson GA; Hachem RR
    Chest; 2021 Nov; 160(5):1743-1750. PubMed ID: 34186034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
    Papaioannou AI; Kostikas K; Manali ED; Papadaki G; Roussou A; Spathis A; Mazioti A; Tomos I; Papanikolaou I; Loukides S; Chainis K; Karakitsos P; Griese M; Papiris S
    PLoS One; 2016; 11(6):e0157789. PubMed ID: 27337142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.